Mar 18,2020 08:50 AM
The company and its officials said that it shall file appeals to the order before the NCLAT within the prescribed time.
What not to miss today Feb 24,2020
What not to miss today Feb 17,2020
|Resolution Type||Description Of Resolution||IiAS Recommendation|
|Name||LTP||PE||Mar Cap||NP Qtr||Div. Yld||Sales Qtr||BV|
|Sun Pharmaceuticals Industries Ltd||402.10||28.87||90,191.00||468.76||0.73||2,920.83||98.33|
|Dr Reddys Laboratories Ltd||3,425.05||19.81||52,257.80||521.70||0.64||3,032.20||852.65|
|Divis Laboratories Ltd||1,983.95||39.72||50,456.29||360.73||0.84||1,390.49||266.77|
|Torrent Pharmaceuticals Ltd||2,257.00||37.59||35,148.69||220.00||0.82||1,436.00||323.64|
Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.
Headquartered in Mumbai, India, Alkem Laboratories Limited is a leading Indian pharmaceutical company with global operations. The company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical ingredients (APIs) and nutraceuticals, which it markets in India and international markets. With a portfolio of more than 700 b... More
Reports by alkem-laboratories-ltd
Apr 07, 2020 10:59 AM
The company’s consolidated revenue in the period stood at Rs1,918.92cr, up 3.22% yoy and 15.66% qoq.
07 Feb 2020
13 Feb 2020
Alkem Laboratories Ltd has informed BSE that the Board of Directors of the Company, at its meeting h... More
07 Feb 2020
29 Jan 2020
Interim Dividend & Quarterly ResultsAlkem Laboratories Ltdhas informed BSE that the meeting of the B... More
11 Nov 2019
18 Oct 2019
Quarterly Results... More